An Open, Dose Escalation, Multiple Dose Study to Assess Tolerance Pharmacokinetics Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)
Phase of Trial: Phase I
Latest Information Update: 14 Oct 2016
At a glance
- Drugs Hitanercept (Primary) ; Etanercept
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
- 07 Jun 2017 Biomarkers information updated
- 08 Oct 2016 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017.
- 08 Oct 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017.